This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
This $83,927.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the delivery of EZ1 ADVANCED XL equipment, which is used for DNA/RNA extraction and sample preparation. This purchase order is not associated with a set-aside program. Qiagen has a history of providing specialized products and services to support...
This is a firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $10,546.00 contract is for QIAXTRACTOR/QIACUBE HT SERVICE, which are likely equipment maintenance and service support for Qiagen's sample processing and diagnostic systems used in federal biomedical research, public health, and healthcare programs. Qiagen has a history of providing a range of products and services to...
This is a $10,397.51 firm-fixed-price delivery order contract awarded by the Defense Health Agency to Qiagen, LLC, a division of the international firm Qiagen N.V. The contract is for the provision of medical supplies, with a period of performance through September 30, 2023. Qiagen has provided a range of products and services supporting federal biomedical research, public health, and healthcare programs, including DNA/RNA extraction kits, sequencing equipment, and bioinformatics software. The...
This federal contract award, valued at $77,258.10, was issued by the Medical Command (MEDCOM) of the U.S. Department of Defense to Qiagen, LLC for the provision of the EZ1 Advanced XL Platform. Qiagen, LLC is a subsidiary of the Qiagen N.V. multinational biotechnology company. The contract is a firm fixed-price purchase order without a set-aside designation. Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, and life sciences research. Under this...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life sciences products. The $211,853.58 contract is for QCII ONE PRECUR 301-600 TESTING and has a performance period ending on May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a substantial portfolio of federal contracts and grants for providing specialized equipment,...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Qiagen, LLC for the delivery of EZ1 DNA BLOOD 350 UL KITS (48). The contract has a ceiling value of $20,961.12 and a completion date of September 29, 2019. Qiagen, LLC is a division of the international provider of sample and assay technologies, Qiagen N.V. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Qiagen, LLC, a subsidiary of Qiagen N.V., for preventive maintenance services. The contract has a ceiling value of $91,667.67 and a completion date of September 30, 2020. The contract was not set aside and was awarded directly to Qiagen, LLC as the prime contractor. Qiagen is an international provider of sample and assay technologies that supports federal agencies' biomedical research,...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer, for $10,026.00 to provide preventative maintenance services for two EZ1 Advanced XL laboratory instruments located at the Naval Medical Research Command's Infectious Diseases Diagnostic Laboratory. The contract has a 12-month period of performance from April 12, 2025 to April 11, 2026 and was awarded without any set-aside designation....